David M. Stern

44.4k total citations · 15 hit papers
201 papers, 32.3k citations indexed

About

David M. Stern is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, David M. Stern has authored 201 papers receiving a total of 32.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Clinical Biochemistry, 66 papers in Molecular Biology and 44 papers in Physiology. Recurrent topics in David M. Stern's work include Advanced Glycation End Products research (68 papers), Alzheimer's disease research and treatments (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (26 papers). David M. Stern is often cited by papers focused on Advanced Glycation End Products research (68 papers), Alzheimer's disease research and treatments (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (26 papers). David M. Stern collaborates with scholars based in United States, Japan and Germany. David M. Stern's co-authors include Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan, Peter P. Nawroth, Yan Lü, Thomas Kislinger, Angelika Bierhaus, Akihiko Taguchi, Wu Qu and Jean‐Luc Wautier and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David M. Stern

198 papers receiving 31.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial cells in physiology and in the pathophysiology of vascular disorders.

1998 1.8k citations Ann Marie Schmidt, David M. Stern et al. profile →
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

1996 1.7k citations Shi Du Yan, Alex E. Roher et al. Nature profile →
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

2000 1.1k citations Akihiko Taguchi, G. Del Toro et al. Nature profile →
Understanding RAGE, the receptor for advanced glycation end products

2005 1.0k citations Angelika Bierhaus, Michael Morcos et al. profile →
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

1995 988 citations Osamu Hori, David M. Stern et al. profile →
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

2001 970 citations Ann Marie Schmidt, Shi Du Yan et al. Journal of Clinical Investigation profile →
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1998 930 citations Yan Lü, David M. Stern et al. Nature Medicine profile →
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

2001 895 citations Ann Marie Schmidt, Shi Du Yan et al. Journal of Clinical Investigation profile →
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

2001 867 citations David M. Stern, Ann Marie Schmidt et al. profile →
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression

1999 763 citations Thomas Kislinger, Caifeng Fu et al. profile →
Activation of Receptor for Advanced Glycation End Products

1999 644 citations Ann Marie Schmidt, Shi Du Yan et al. profile →
Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

2005 626 citations Alexander A. Sosunov, David M. Stern et al. profile →
The biology of the receptor for advanced glycation end products and its ligands

2000 587 citations Ann Marie Schmidt, Shi Du Yan et al. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research profile →
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model

2004 566 citations Akihiko Taguchi, Toshihiro Soma et al. Journal of Clinical Investigation profile →
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model

2004 516 citations Akihiko Taguchi, Toshihiro Soma et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by David M. Stern

Since Specialization

Citations

This map shows the geographic impact of David M. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Stern more than expected).

Fields of papers citing papers by David M. Stern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Stern. The network helps show where David M. Stern may publish in the future.

Co-authorship network of co-authors of David M. Stern

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Stern. A scholar is included among the top collaborators of David M. Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Stern. David M. Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients 2015 ·Stem Cells and Development ·Akihiko Taguchi, Chiaki Sakai, Toshihiro Soma, Yukiko Kasahara, David M. Stern, Katsufumi Kajimoto, Masafumi Ihara, Takashi Daimon, Kenichi Yamahara, (unknown), Nobuo Kohara, Hiroyuki Nishimura, Tomohiro Matsuyama, Hiroaki Naritomi, Nobuyuki Sakai, Kazuyuki Nagatsuka	84
2	Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging inC. elegans 2010 ·Aging Cell ·Andreas Schlotterer, Andreas Hamann, G Kukudov, Youssef Ibrahim, (unknown), Farastuk Bozorgmehr, Michael Pfeiffer, Harald Hutter, David M. Stern, Xueliang Du, Michael Brownlee, Angelika Bierhaus, Peter P. Nawroth, Michael Morcos	22
3	RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction 2009 ·Proceedings of the National Academy of Sciences ·Kazuhiro Takuma, Fang Fang, Wensheng Zhang, Shiqiang Yan, (unknown), Heng Du, Alexander A. Sosunov, Guy M. McKhann, Yoko Funatsu, Noritaka Nakamichi, Taku Nagai, Hiroyuki Mizoguchi, Daisuke Ibi, Osamu Hori, Satoshi Ogawa, David M. Stern, Kiyofumi Yamada, (unknown)	250
4	The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism 2005 ·Journal of Clinical Investigation ·Kazuhiro Abeyama, David M. Stern, Yuji Ito, Koichi Kawahara, Yasushi Yoshimoto, Motoyuki Tanaka, Tomonori Uchimura, Nobuo Ida, Yoshiaki Yamazaki, Shingo Yamada, Yasuhiko Yamamoto, Hiroshi Yamamoto, Satoshi Iino, Noboru Taniguchi, Ikuro Maruyama	437
5	The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism 2005 ·Journal of Clinical Investigation ·Kazuhiro Abeyama, David M. Stern, Yuji Ito, Koichi Kawahara, Yasushi Yoshimoto, Motoyuki Tanaka, Tomonori Uchimura, Nobuo Ida, Yoshiaki Yamazaki, Shingo Yamada, Yasuhiko Yamamoto, Hiroshi Yamamoto, Satoshi Iino, Naoyuki Taniguchi, Ikuro Maruyama	46
6	The marriage of glucose and blood vessels: It isn’t all that sweet 2005 ·Cell Metabolism ·Wen‐Cheng Xiong, David M. Stern	1
7	Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model breakdown → 2004 ·Journal of Clinical Investigation ·Akihiko Taguchi, Toshihiro Soma, Hidekazu Tanaka, Takayoshi Kanda, Hiroyuki Nishimura, Hiroo Yoshikawa, Yoshitane Tsukamoto, Hiroyuki Iso, Yoshihiro Fujimori, David M. Stern, Hiroaki Naritomi, Tomohiro Matsuyama	566
8	Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products 2004 ·The Journal of Immunology ·Yali Chen, Shirley ShiDu Yan, John Colgan, Huiping Zhang, Jeremy Luban, Ann Marie Schmidt, David M. Stern, Kevan C. Herold	109
9	Central role of RAGE-dependent neointimal expansion in arterial restenosis 2003 ·Journal of Clinical Investigation ·Taichi Sakaguchi, Shi Fang Yan, Shi Du Yan, Dmitri Belov, Ling Rong, Mónica Mendes Sousa, Martin Andrassy, Steven P. Marso, Stephan H. Duda, Bernd Arnold, Birgit Liliensiek, Peter P. Nawroth, David M. Stern, Ann Marie Schmidt, Yoshifumi Naka	296
10	Glycation and diabetes: The RAGE connection 2002 ·Current Science ·Barry I. Hudson, M. Hofmann, Loredana Bucciarelli, Thoralf Wendt, Bernhard Moser, Yan Lü, Wu Qu, David M. Stern, Vivette D. D’Agati, Shirley ShiDu Yan, Shi Fang Yan, Peter J. Grant, Ann Marie Schmidt	41
11	Series Introduction: Multiligand receptors and human disease 2001 ·Journal of Clinical Investigation ·Monty Krieger, David M. Stern	43
12	Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease 2000 ·Journal of the American Society of Nephrology ·Nozomu Tanji, Glen S. Markowitz, Caifeng Fu, Thomas Kislinger, Akihiko Taguchi, Monika Pischetsrieder, David M. Stern, Ann Marie Schmidt, Vivette D. D’Agati	399
13	Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Shi Du Yan, Alex E. Roher, Michael P. Chaney, Berislav V. Zloković, A M Schmidt, David M. Stern	50
14	Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases breakdown → 2000 ·Nature ·Akihiko Taguchi, (unknown), G. Del Toro, (unknown), (unknown), Wu Qu, Nozomu Tanji, Yan Lu, Evanthia Lalla, Caifeng Fu, M. Hofmann, Thomas Kislinger, Mark Ingram, Amy Lu, Hidekazu Tanaka, Osamu Hori, Satoshi Ogawa, David M. Stern, Ann Marie Schmidt	1058
15	The biology of the receptor for advanced glycation end products and its ligands breakdown → 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan, David M. Stern	587
16	Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress 2000 ·Nature Medicine ·Shi-Fang Yan, Tomoyuki Fujita, Jiesheng Lu, Kenji Okada, Yu Zou, Nigel Mackman, David J. Pinsky, David M. Stern	405
17	RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes 2000 ·Trends in Endocrinology and Metabolism ·Ann Marie Schmidt, David M. Stern	131
18	α-Galactosyl epitopes on glycoproteins of porcine renal extracellular matrix 2000 ·Kidney International ·(unknown), Edward Cantu, Uri Galili, Vivette D. D’Agati, Gabriel C. Godman, David M. Stern, Giuseppe A. Andres	13
19	Membranous Glomerulonephritis Induced in the Pig by Antibody to Angiotensin-Converting Enzyme 1999 ·Journal of the American Society of Nephrology ·Shoichi Maruyama, Edward Cantu, (unknown), Adrian O. Vladutiu, P. R. B. Caldwell, Catherine Y. Wang, Vivette D. D’Agati, Gabriel C. Godman, David M. Stern, Giuseppe A. Andres	8
20	Regulation of the Coagulation System by Vascular Endothelial Cells 1988 ·Pathophysiology of Haemostasis and Thrombosis ·David M. Stern, (unknown), Peter P. Nawroth	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact